Fourth Circuit Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 11 - 20 of 47
RSS Feed | View as table
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00089
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00085
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff: Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NOVARTIS PHARMACEUTICALS CORPORATION et al v. ACCORD HEALTHCARE INC. et al
as 1:2022cv00431
Plaintiff: NOVARTIS PHARMACEUTICALS CORPORATION and Dana-Farber Cancer Institute, Inc.
Defendant: ACCORD HEALTHCARE INC. and INTAS PHARMACEUTICALS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00032
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al We have downloadable decisions or orders for this case
as 1:2022cv00020
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc
Defendant: Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Nexus Pharmaceuticals, Inc. v. Nephron SC, Inc. We have downloadable decisions or orders for this case
as 3:2022cv00137
Plaintiff: Nexus Pharmaceuticals, Inc.
Defendant: Nephron SC, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00146
Plaintiff: Novartis Pharmaceuticals Corporation
Defendant: Mylan Pharmaceuticals Inc., Mylan Inc., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
PFIZER, INC. et al v. SYNTHON PHARMACEUTICALS, INC. et al
as 1:2021cv00817
Plaintiff: PFIZER, INC., WARNER-LAMBERT COMPANY LLC and PF PRISM IMB B.V.
Defendant: SYNTHON PHARMACEUTICALS, INC., SYNTHON B.V. and SYNTHON INTERNATIONAL HOLDING B.V.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00099
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?